Krystal Biotech (KRYS) Inventory (2023 - 2026)

Krystal Biotech has disclosed Inventory across 4 years of filings, most recently posting $42.6 million for Q1 2026.

• Inventory for Q1 2026 came in at $42.6 million, up 42.43% year-over-year; the trailing twelve-month figure through Mar 2026 was $42.6 million (up 42.43% YoY), and the FY2025 annual result was $40.5 million, up 52.69% from the prior year.
• Inventory came in at $42.6 million for Q1 2026 at Krystal Biotech, up from $40.5 million in the prior quarter.
• In the past five years, Inventory ranged from a high of $42.6 million in Q1 2026 to a low of $5.3 million in Q3 2023.
• The 4-year median for Inventory is $26.5 million (2024), against an average of $23.8 million.
• Across the five-year window, Inventory surged 279.5% in 2024 and surged 42.43% in 2026, its largest moves.
• Krystal Biotech's Inventory stood at $7.0 million in 2023, then soared by 279.5% to $26.5 million in 2024, then surged by 52.69% to $40.5 million in 2025, then advanced by 5.36% to $42.6 million in 2026.
• The last three Inventory figures came in at $42.6 million (Q1 2026), $40.5 million (Q4 2025), and $37.6 million (Q3 2025), per Business Quant data.